Last reviewed · How we verify
Spinal anesthesia for lumbar surgery: ropivacaine
Spinal anesthesia for lumbar surgery: ropivacaine is a Small molecule drug developed by Fraser Health. It is currently in Phase 1 development. Also known as: Ropivacaine in the spinal anesthesia for lower lumbar surgery.
At a glance
| Generic name | Spinal anesthesia for lumbar surgery: ropivacaine |
|---|---|
| Also known as | Ropivacaine in the spinal anesthesia for lower lumbar surgery |
| Sponsor | Fraser Health |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Contrast and Anesthetic Level With Lumbar Erector Spinae Plan (ESP) Block (NA)
- PENG Block vs Suprainguinal FICB vs Lumbar ESPB for Analgesia After Hip Surgery (NA)
- Continuous Erector Spinae Block for Analgesia Following Lumbar Decompression (NA)
- Observational Retrospective Study on Spinal Analgesia in Laparoscopic and Laparotomic Hysterectomy
- Comparison Between 2 Techniques for Lumbar-ESPB (NA)
- Effect of RECK in Posterior Spinal Fusion (PHASE1, PHASE2)
- The Role of Precision Anesthesia Strategy on Perioperative Organ Protection in Hip Surgery [PASPOP] (NA)
- Testing the Feasibility of Using Ropivacaine in Spinal Anesthesia for Patients With Lower Back Surgery (EARLY_PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Spinal anesthesia for lumbar surgery: ropivacaine CI brief — competitive landscape report
- Spinal anesthesia for lumbar surgery: ropivacaine updates RSS · CI watch RSS
- Fraser Health portfolio CI
Frequently asked questions about Spinal anesthesia for lumbar surgery: ropivacaine
What is Spinal anesthesia for lumbar surgery: ropivacaine?
Spinal anesthesia for lumbar surgery: ropivacaine is a Small molecule drug developed by Fraser Health.
Who makes Spinal anesthesia for lumbar surgery: ropivacaine?
Spinal anesthesia for lumbar surgery: ropivacaine is developed by Fraser Health (see full Fraser Health pipeline at /company/fraser-health).
Is Spinal anesthesia for lumbar surgery: ropivacaine also known as anything else?
Spinal anesthesia for lumbar surgery: ropivacaine is also known as Ropivacaine in the spinal anesthesia for lower lumbar surgery.
What development phase is Spinal anesthesia for lumbar surgery: ropivacaine in?
Spinal anesthesia for lumbar surgery: ropivacaine is in Phase 1.
Related
- Manufacturer: Fraser Health — full pipeline
- Also known as: Ropivacaine in the spinal anesthesia for lower lumbar surgery
- Compare: Spinal anesthesia for lumbar surgery: ropivacaine vs similar drugs
- Pricing: Spinal anesthesia for lumbar surgery: ropivacaine cost, discount & access